anas-al-janadi
Anas Al-Janadi, MD
Associate Professor of Medicine

Education

DEGREE DEPARTMENT UNIVERSITY YEAR
M.D Physical Therapy Damascus University School of Medicine 1986-1991
Fellow Hematology/Oncology Henry Ford Health System/Josephine Ford Cancer Center 1998-2001               
Resident Internal Medicine St. Barnabas Hospital/Cornell Medical Center, Bronx, NY 1995-1998

Biography

Al-Janadi received his Doctor of Medicine degree at Damascus University School of Medicine. In June of 2006, he joined the Department of Medicine at MSU and recently accepted the permanent position as Chief of MSU Hematology/Oncology division in the Department of Medicine in the College of Human Medicine. MSHO is grateful for Dr. Al-Janadi’s contributions to the Society and his desire to become active in the development of MSHO’s mission for the advancement of oncology in Michigan.


Research Interest

  • Hematology
  • Oncology

Scientific Activities

Employment History
2010 -present. Associate Professor, Department of Medicine, Michigan State University
2011- present Chief, Division of Hematology/Oncology, Department of Medicine, Michigan State University
2010-2011 Interim Chief, Division of Hematology/Oncology, Department of Medicine, Michigan State University
2010-present Program Director, Hematology/Oncology Fellowship Program, Michigan State University
2006 -2010 Assistant Professor, Department of Medicine, Michigan State University
2008-present Director, Breslin Cancer Center at Michigan State University
2010 - 2013 Professor, Department of Physical Therapy, College of Health Science, Korea University, Seoul Korea.
2007 -20103 Associate Medical Director, Great Lakes Cancer Institute, Lansing, MI
2003-2008 Assistant Professor, Department of Health Sciences, Cleveland State University, Cleveland, OH.
2010-2013 Chairperson, Cancer Committee, Ingham Regional Medical Center, Lansing, MI
Honors and Awards
  • ECFMG - certified, 1995
  • Board Certified, Internal Medicine, 1998
  • Board Certified, Medical Oncology- Recertified in 2011, participating in MOC program 2001
  • Board Certified, Hematology- Recertified in 2011, participating in MOC program, 2001
  • Principal Investigator on over 70 clinical trials including investigator-initiated, intergroup, and pharmaceutical sponsored studies, with focus on Hematology, GU malignancies, and Immunotherapy studies

Publications

  1. Ahmad D, Akkad M, Olsen B, Al-Janadi AHemophagocytic Lymphohistiocytosis in a Patient with Nodular Lymphocyte–Predominant Hodgkin Lymphoma AJHO. 2017;13(2):4-8
  2. Kannarkatt J, Kurniali P, Al-Janadi A, Hrinczenko B Adjuvant Chemotherapy for Stage II Colon Cancer: A Clinical Dilemma J Oncol Pract. 2017 Apr;13(4):233-241
  3. Kurniali PC, Hrinczenko B, Al-Janadi A Management of Advanced and Metastatic Colon Cancer in Elderly Patients. World J Gastroenterol. 2014 Feb 28;20(8):1910-1922. PMID: 24616568
  4. Kurniali PC, Kavuturu S, Caliman N, Al-Janadi A Thyroid Metastasis from Squamous Cell Carcinoma of Gallbladder. J Gastrointest Cancer. 2013 Oct 15. [Epub ahead of print]. PMID: 24126841
  5. Al-Janadi A, Hrinczenko B, Chaudhary V, Chitneni S, Ali S, Saultz J, Dimitrov NV. Musculoskeletal events associated with the management of endocrine-responsive breast cancer. Oncology Reviews 2010; 4(3): 185-189
  6. Tamkus D, Al-Janadi A, Fink G, Krishnan G, Dimitrov NV. Endothelins as a Potential Target for Anticancer Therapy. Journal of Cancer Molecules 4(6): 163-167, 2009
  7. Al-Janadi A, Chandana SR, Conley BA. Histone deacetylation: an attractive target for cancer therapy? Drugs R D 2008; 9(6):369-83
  8. Krishnan GS, Chaudhary V, Ramanarayanan J, D'Silva K, Al-Janadi A BCNU Toxicity Presenting with a Large Pericardial and Pleural Effusion. Ann Transplant 13(1):44-47, 2008.
  9. Krishnan GS, D’Silva K, Al-Janadi A Cetuximab Induced Tumor Lysis Syndrome in a Patient with Metastatic Colon Carcinoma. J Clin Oncl 26(14):2406-2408, 2008.
Book Chapter

Kurniali, PC, Al-Janadi, A Cancer Therapy and Their Applications. In: Dinesh Vyas (editor), Comprehensive Textbook of Surgery, 2nd Edition, 2014 ISBN: 9350250527.


     
Autoimmune Journal Flyer